HPV vaccination offers significant protection against cervical cancer

Organisation: Position: Deadline Date: Location:

After analysing data from the first human papillomavirus (HPV) vaccination programme in Australia, researchers have found that the vaccine offers significant protection against cervical abnormalities, reports [s]Medical News Today[/s]. HPV is a virus that can affect human skin and the moist membranes that line the body, such as the cervix, anus, mouth and throat and according to [b]Australia’s National Cancer Institute[/b], cervical cancer – of which there are expected to be 12,340 new cases this year – is almost always caused by HPV infection. The report says at present there are two HPV vaccines available worldwide [b]Gardasil[/b] and [b]Cervarix[/b] and studies have shown that both vaccines are effective in preventing cervical cancer in young women, as well as g enital warts and high-grade anal disease in men.
Full Medical News Today report
BMJ article


Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.